PTC299 Terminated Phase 2 Trials for Neurofibromatosis 2 Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00911248PTC299 for Treatment of Neurofibromatosis Type 2